首页 > 最新文献

Clinical, Cosmetic and Investigational Dermatology最新文献

英文 中文
Pulsed Dye Laser for Port Wine Stains in 974 Children: A 20-Year Study in China. 脉冲染料激光治疗 974 名儿童的葡萄酒色斑:中国一项为期 20 年的研究
IF 1.9 4区 医学 Q3 DERMATOLOGY Pub Date : 2024-11-14 eCollection Date: 2024-01-01 DOI: 10.2147/CCID.S487229
Bingyu Xiu, Zhe Xu, Zigang Xu, Bin Zhang, Li Wei, Lin Ma

Importance: Port-wine stain (PWS) is a congenital vascular condition involving dilation of skin capillaries and venules, significantly affecting patients' physical and mental health. Pulsed dye laser (PDL) is widely used for PWS treatment; however, large-scale data on pediatric cases remain limited. This retrospective study aims to investigate the efficacy of laser treatment and its related factors in a large sample.

Objective: To assess the clinical efficacy and adverse reactions of 595nm PDL for treating pediatric PWS and to identify factors influencing treatment outcomes.

Methods: This retrospective study included 974 pediatric patients with PWS treated at Beijing Children's Hospital from 2003 to 2021. Inclusion criteria required patients to be under 18, with solitary PWS and Fitzpatrick skin types II-IV. Treatment efficacy was evaluated using standardized photographs taken before and after treatment, with outcomes categorized by Achauer's clearance criteria. Ridit analysis assessed the impact of variables such as gender, age, lesion location, and treatment frequency on outcomes.

Results: The overall efficacy rate was 65.3%, higher in females (69.7%) than males (59.7%). Adolescents had the highest efficacy (100%) due to better compliance. Limb lesions responded best (87.5%), followed by neck (75.0%), trunk (66.7%), and head/face (63.0%). Smaller lesions (≤3 cm²) achieved 76.8% efficacy. Efficacy rose with sessions, reaching 84.0% after three. The mandibular branch (V3) had the highest trigeminal efficacy (68.5%). Adverse reactions (4.31%) included pigmentation changes (2.87%), hypopigmentation (1.03%), and minimal scarring (0.41%).

Conclusion: The efficacy of 595nm PDL for treating PWS in children is influenced by gender, age, lesion location, size, and the number of treatment sessions. PDL is an effective treatment for pediatric PWS with minimal adverse reactions.

重要性:葡萄酒港染色(PWS)是一种先天性血管疾病,涉及皮肤毛细血管和静脉扩张,严重影响患者的身心健康。脉冲染料激光(PDL)被广泛用于治疗葡萄酒港斑,但有关儿科病例的大规模数据仍然有限。这项回顾性研究旨在通过大样本调查激光治疗的疗效及其相关因素:评估 595nm PDL 治疗小儿 PWS 的临床疗效和不良反应,并确定影响治疗结果的因素:这项回顾性研究纳入了2003年至2021年在北京儿童医院接受治疗的974例小儿PWS患者。纳入标准要求患者年龄在18岁以下,患有单发性PWS,皮肤类型为Fitzpatrick II-IV型。采用治疗前后的标准化照片评估疗效,疗效按阿考尔清除标准进行分类。Ridit分析评估了性别、年龄、皮损位置和治疗频率等变量对疗效的影响:总体有效率为 65.3%,女性(69.7%)高于男性(59.7%)。由于依从性较好,青少年的疗效最高(100%)。四肢病变反应最好(87.5%),其次是颈部(75.0%)、躯干(66.7%)和头面部(63.0%)。较小病灶(≤3 平方厘米)的疗效为 76.8%。疗效随疗程增加而上升,三次疗程后达到 84.0%。下颌分支(V3)的三叉神经疗效最高(68.5%)。不良反应(4.31%)包括色素变化(2.87%)、色素沉着(1.03%)和轻微瘢痕(0.41%):结论:595nm PDL 治疗儿童 PWS 的疗效受性别、年龄、皮损位置、大小和治疗次数的影响。PDL是治疗儿童PWS的有效方法,且不良反应极少。
{"title":"Pulsed Dye Laser for Port Wine Stains in 974 Children: A 20-Year Study in China.","authors":"Bingyu Xiu, Zhe Xu, Zigang Xu, Bin Zhang, Li Wei, Lin Ma","doi":"10.2147/CCID.S487229","DOIUrl":"10.2147/CCID.S487229","url":null,"abstract":"<p><strong>Importance: </strong>Port-wine stain (PWS) is a congenital vascular condition involving dilation of skin capillaries and venules, significantly affecting patients' physical and mental health. Pulsed dye laser (PDL) is widely used for PWS treatment; however, large-scale data on pediatric cases remain limited. This retrospective study aims to investigate the efficacy of laser treatment and its related factors in a large sample.</p><p><strong>Objective: </strong>To assess the clinical efficacy and adverse reactions of 595nm PDL for treating pediatric PWS and to identify factors influencing treatment outcomes.</p><p><strong>Methods: </strong>This retrospective study included 974 pediatric patients with PWS treated at Beijing Children's Hospital from 2003 to 2021. Inclusion criteria required patients to be under 18, with solitary PWS and Fitzpatrick skin types II-IV. Treatment efficacy was evaluated using standardized photographs taken before and after treatment, with outcomes categorized by Achauer's clearance criteria. Ridit analysis assessed the impact of variables such as gender, age, lesion location, and treatment frequency on outcomes.</p><p><strong>Results: </strong>The overall efficacy rate was 65.3%, higher in females (69.7%) than males (59.7%). Adolescents had the highest efficacy (100%) due to better compliance. Limb lesions responded best (87.5%), followed by neck (75.0%), trunk (66.7%), and head/face (63.0%). Smaller lesions (≤3 cm²) achieved 76.8% efficacy. Efficacy rose with sessions, reaching 84.0% after three. The mandibular branch (V3) had the highest trigeminal efficacy (68.5%). Adverse reactions (4.31%) included pigmentation changes (2.87%), hypopigmentation (1.03%), and minimal scarring (0.41%).</p><p><strong>Conclusion: </strong>The efficacy of 595nm PDL for treating PWS in children is influenced by gender, age, lesion location, size, and the number of treatment sessions. PDL is an effective treatment for pediatric PWS with minimal adverse reactions.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"17 ","pages":"2573-2581"},"PeriodicalIF":1.9,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572471/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Biomechanical Forces in the Formation and Treatment of Pathological Scars. 生物力学力在病理性疤痕的形成和治疗中的作用。
IF 1.9 4区 医学 Q3 DERMATOLOGY Pub Date : 2024-11-13 eCollection Date: 2024-01-01 DOI: 10.2147/CCID.S496253
Guangtong Cao, Mingmin Ye, Haiyan Wang, Yi Liu, Mengzhi Li

Pathological scars, including hypertrophic scar and keloid are the result of excessive tissue repair and are influenced by biomechanical forces like tension, mechanical pressure, and stiffness. These forces significantly impact scar development and progression, affecting wound healing, collagen deposition, and tissue remodeling. Understanding how these mechanical stimuli contribute to scar development is essential for devising effective therapeutic interventions. Clinically, reducing wound tension and applying mechanical pressure are key strategies for managing pathological scars. Techniques like super-tension-reduction suturing, stress-shielding polymers, and force-modulating tissue bridges (FMTB) have been shown to effectively alleviate tension and reduce scar proliferation. Additionally, Pressure Garment Therapy (PGT) is widely used to treat hypertrophic scars by reducing tissue stiffness, limiting collagen buildup, and promoting collagen realignment. Despite challenges such as discomfort and uneven pressure application, ongoing research focuses on enhancing these therapies through mechanosensitive technologies to improve both efficacy and patient comfort. This review highlights the role of biomechanical forces in scar formation and discusses therapeutic approaches that target these forces to improve clinical outcomes.

病理性疤痕(包括增生性疤痕和瘢痕疙瘩)是组织过度修复的结果,受到生物力学力(如张力、机械压力和硬度)的影响。这些力对疤痕的形成和发展有重大影响,会影响伤口愈合、胶原蛋白沉积和组织重塑。了解这些机械刺激是如何导致疤痕形成的,对于制定有效的治疗干预措施至关重要。在临床上,降低伤口张力和施加机械压力是治疗病理性疤痕的关键策略。超张力减张缝合、应力屏蔽聚合物和力调控组织桥(FMTB)等技术已被证明能有效缓解张力,减少疤痕增生。此外,压力衣疗法(PGT)也被广泛用于治疗增生性疤痕,它能降低组织僵硬度、限制胶原蛋白堆积并促进胶原蛋白重新排列。尽管存在不适和施压不均等问题,但目前的研究重点是通过机械敏感技术来提高这些疗法的疗效和患者的舒适度。本综述强调了生物力学力在疤痕形成中的作用,并讨论了针对这些作用力的治疗方法,以改善临床效果。
{"title":"The Role of Biomechanical Forces in the Formation and Treatment of Pathological Scars.","authors":"Guangtong Cao, Mingmin Ye, Haiyan Wang, Yi Liu, Mengzhi Li","doi":"10.2147/CCID.S496253","DOIUrl":"10.2147/CCID.S496253","url":null,"abstract":"<p><p>Pathological scars, including hypertrophic scar and keloid are the result of excessive tissue repair and are influenced by biomechanical forces like tension, mechanical pressure, and stiffness. These forces significantly impact scar development and progression, affecting wound healing, collagen deposition, and tissue remodeling. Understanding how these mechanical stimuli contribute to scar development is essential for devising effective therapeutic interventions. Clinically, reducing wound tension and applying mechanical pressure are key strategies for managing pathological scars. Techniques like super-tension-reduction suturing, stress-shielding polymers, and force-modulating tissue bridges (FMTB) have been shown to effectively alleviate tension and reduce scar proliferation. Additionally, Pressure Garment Therapy (PGT) is widely used to treat hypertrophic scars by reducing tissue stiffness, limiting collagen buildup, and promoting collagen realignment. Despite challenges such as discomfort and uneven pressure application, ongoing research focuses on enhancing these therapies through mechanosensitive technologies to improve both efficacy and patient comfort. This review highlights the role of biomechanical forces in scar formation and discusses therapeutic approaches that target these forces to improve clinical outcomes.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"17 ","pages":"2565-2571"},"PeriodicalIF":1.9,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association Between Life's Essential 8 and Psoriasis in American Adults: A Cross-Sectional NHANES Study. 美国成年人生活必需品 8 与牛皮癣之间的关系:一项横断面 NHANES 研究。
IF 1.9 4区 医学 Q3 DERMATOLOGY Pub Date : 2024-11-12 eCollection Date: 2024-01-01 DOI: 10.2147/CCID.S476594
Weiqing Zhang, Zengze Yuan, Yihan Wang, Zhaokai Jin, Ziyue Luo, Xinchang Wang

Purpose: Life's Essentials 8 (LE8) is a new indicator developed by the American Heart Association to assess cardiovascular health, including diet, physical activity, nicotine exposure, sleep health, body mass index, blood lipids, blood glucose and blood pressure. And more and more studies have shown that this index can evaluate other diseases, such as chronic kidney disease, abdominal aortic calcification and so on. However, there is no relevant study to evaluate the association between LE8 and psoriasis. The purpose of this study was to investigate the relationship between LE8 and the prevalence of psoriasis in American adults.

Patients and methods: The data are from the National Health and Nutrition Examination Survey (NHANES) of the United States from 2003 to 2006, 2009 to 2014. Psoriasis was the dependent variable. LE8 is an independent variable and is divided into three levels: high, medium and low. Multivariate logistic regression model was used to explore the relationship between LE8 and psoriasis.

Results: A total of 13430 people were included in this study, including 391 patients with psoriasis and 13039 patients without psoriasis. The prevalence of psoriasis was 2.91%. In the fully adjusted logistic regression model, LE8 score was negatively correlated with psoriasis (OR=0.99; 95% CI, 0.98-0.99, P=0.0003). And this result still exists when LE8 is divided into high, medium and low groups. Compared with the low LE8 group, the high LE8 group had a 61% lower risk of psoriasis (OR=0.39; 95% CI, 0.26-0.57, p <0.0001).

Conclusion: This cross-sectional study suggested that LE8 score was negatively correlated with psoriasis risk.

目的:LE8(Life's Essentials 8)是美国心脏协会开发的一项评估心血管健康的新指标,包括饮食、体力活动、尼古丁暴露、睡眠健康、体重指数、血脂、血糖和血压。越来越多的研究表明,该指数还可以评估其他疾病,如慢性肾病、腹主动脉钙化等。然而,目前还没有相关研究评估 LE8 与银屑病之间的关联。本研究旨在调查 LE8 与美国成年人银屑病患病率之间的关系:数据来自 2003 年至 2006 年、2009 年至 2014 年的美国国家健康与营养调查(NHANES)。牛皮癣是因变量。LE8为自变量,分为高、中、低三个等级。采用多变量逻辑回归模型探讨LE8与银屑病之间的关系:本研究共纳入 13430 人,其中银屑病患者 391 人,非银屑病患者 13039 人。银屑病发病率为 2.91%。在完全调整的逻辑回归模型中,LE8 评分与银屑病呈负相关(OR=0.99;95% CI,0.98-0.99,P=0.0003)。当 LE8 分为高、中、低三组时,这一结果依然存在。与 LE8 低组别相比,LE8 高组别患银屑病的风险降低了 61%(OR=0.39;95% CI,0.26-0.57,P 结论:LE8 高组别与 LE8 低组别相比,患银屑病的风险降低了 61%:这项横断面研究表明,LE8 评分与银屑病风险呈负相关。
{"title":"The Association Between Life's Essential 8 and Psoriasis in American Adults: A Cross-Sectional NHANES Study.","authors":"Weiqing Zhang, Zengze Yuan, Yihan Wang, Zhaokai Jin, Ziyue Luo, Xinchang Wang","doi":"10.2147/CCID.S476594","DOIUrl":"10.2147/CCID.S476594","url":null,"abstract":"<p><strong>Purpose: </strong>Life's Essentials 8 (LE8) is a new indicator developed by the American Heart Association to assess cardiovascular health, including diet, physical activity, nicotine exposure, sleep health, body mass index, blood lipids, blood glucose and blood pressure. And more and more studies have shown that this index can evaluate other diseases, such as chronic kidney disease, abdominal aortic calcification and so on. However, there is no relevant study to evaluate the association between LE8 and psoriasis. The purpose of this study was to investigate the relationship between LE8 and the prevalence of psoriasis in American adults.</p><p><strong>Patients and methods: </strong>The data are from the National Health and Nutrition Examination Survey (NHANES) of the United States from 2003 to 2006, 2009 to 2014. Psoriasis was the dependent variable. LE8 is an independent variable and is divided into three levels: high, medium and low. Multivariate logistic regression model was used to explore the relationship between LE8 and psoriasis.</p><p><strong>Results: </strong>A total of 13430 people were included in this study, including 391 patients with psoriasis and 13039 patients without psoriasis. The prevalence of psoriasis was 2.91%. In the fully adjusted logistic regression model, LE8 score was negatively correlated with psoriasis (OR=0.99; 95% CI, 0.98-0.99, P=0.0003). And this result still exists when LE8 is divided into high, medium and low groups. Compared with the low LE8 group, the high LE8 group had a 61% lower risk of psoriasis (OR=0.39; 95% CI, 0.26-0.57, p <0.0001).</p><p><strong>Conclusion: </strong>This cross-sectional study suggested that LE8 score was negatively correlated with psoriasis risk.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"17 ","pages":"2555-2563"},"PeriodicalIF":1.9,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568770/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of Mid-Face Aging with Calcium Hydroxylapatite: Focus on Retaining Ligament Support. 用羟基磷灰石钙治疗中面部老化:注重保留韧带支撑。
IF 1.9 4区 医学 Q3 DERMATOLOGY Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.2147/CCID.S468447
Mauricio Sato, Mariana Muniz, Luis Ricardo Coelho Ferreira

The mid-face has been rendered as the cornerstone of facial aesthetic improvement, since treating the mid-face has also beneficial effects on neighboring esthetic units and therefore should be one of the first areas to be assessed. Retaining ligaments (RL) bind soft tissue layers of the face to the underlying facial skeleton. It remains controversial whether RL suffers laxity with aging or if changes in 42 bone and other structures where ligaments are inserted lead to altered mechanical function of the latter. Enhancement of the supportive effect of the ligaments could help restore the soft tissues to their original anatomical positions and achieve a lifting effect. While injectable hyaluronic acid implants have been used to improve ligament support, calcium hydroxylapatite has one of the highest viscoelasticities when compared with other dermal fillers and can induce collagen synthesis, which could provide long-term laxity correction. In this preliminary report of a case series, our goal was to describe the use of calcium hydroxylapatite in different dilutions and combinations for different aging profiles to treat the midface as an alternative for hyaluronic acid injections and to describe the ultrasonographic behavior in the long run.

中面部被视为面部美学改善的基石,因为对中面部的治疗也会对邻近的美学单元产生有益的影响,因此中面部应该是最先被评估的部位之一。保持韧带(RL)将面部软组织层与下层面部骨骼结合在一起。韧带是否会随着年龄的增长而松弛,或者韧带所在的 42 块骨骼和其他结构的变化是否会导致韧带的机械功能发生改变,目前仍存在争议。增强韧带的支撑作用有助于将软组织恢复到原来的解剖位置,达到提升效果。虽然透明质酸注射植入物已被用于改善韧带支撑效果,但与其他皮肤填充物相比,羟基磷灰石钙具有最高的粘弹性,可诱导胶原蛋白合成,从而实现长期松弛矫正。在这份病例系列的初步报告中,我们的目标是描述不同稀释度和不同组合的羟基磷灰石钙在治疗中面部老化方面的应用,以替代透明质酸注射,并描述超声波的长期表现。
{"title":"Treatment of Mid-Face Aging with Calcium Hydroxylapatite: Focus on Retaining Ligament Support.","authors":"Mauricio Sato, Mariana Muniz, Luis Ricardo Coelho Ferreira","doi":"10.2147/CCID.S468447","DOIUrl":"10.2147/CCID.S468447","url":null,"abstract":"<p><p>The mid-face has been rendered as the cornerstone of facial aesthetic improvement, since treating the mid-face has also beneficial effects on neighboring esthetic units and therefore should be one of the first areas to be assessed. Retaining ligaments (RL) bind soft tissue layers of the face to the underlying facial skeleton. It remains controversial whether RL suffers laxity with aging or if changes in 42 bone and other structures where ligaments are inserted lead to altered mechanical function of the latter. Enhancement of the supportive effect of the ligaments could help restore the soft tissues to their original anatomical positions and achieve a lifting effect. While injectable hyaluronic acid implants have been used to improve ligament support, calcium hydroxylapatite has one of the highest viscoelasticities when compared with other dermal fillers and can induce collagen synthesis, which could provide long-term laxity correction. In this preliminary report of a case series, our goal was to describe the use of calcium hydroxylapatite in different dilutions and combinations for different aging profiles to treat the midface as an alternative for hyaluronic acid injections and to describe the ultrasonographic behavior in the long run.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"17 ","pages":"2545-2553"},"PeriodicalIF":1.9,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11566585/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship Between Angiotensin-Converting Enzyme Gene I/D Polymorphism and Psoriasis, Including Psoriasis with Comorbid Hypertension and Diabetes. 血管紧张素转换酶基因 I/D 多态性与银屑病(包括合并高血压和糖尿病的银屑病)的关系
IF 1.9 4区 医学 Q3 DERMATOLOGY Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.2147/CCID.S482663
Jiayun Liu, Rui Sun, Guomin Gao, Mogen Zhang, Huiping Fan, Xiaonan Ma, Yanhong Yu, Yanmei Yuan, Lulu Zhang, Changying Niu

Objective: The relationship between angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism and psoriasis remains unclear. This study aims to analyze the association between ACE gene I/D polymorphism and the risk of psoriasis vulgaris in the Chinese Han population and to examine the correlation between ACE gene I/D polymorphism and psoriasis with comorbid hypertension and diabetes.

Methods: A total of 358 patients with psoriasis vulgaris and 347 age- and sex-matched healthy volunteers from the Chinese Han population were selected. Clinical data, including blood pressure and fasting blood glucose, were collected from the patients. The ACE gene I/D polymorphism was analyzed using polymerase chain reaction (PCR). The association between ACE gene I/D polymorphism and psoriasis vulgaris, as well as comorbid hypertension and diabetes, was analyzed using the Pearson χ²-test.

Results: The frequency of the ACE II genotype (OR = 1.84, 95% CI = 1.30, 2.61; P < 0.01) and the I allele (OR = 1.51, 95% CI = 1.22, 1.86; P < 0.01) was significantly higher in psoriasis patients compared to the control group. Conversely, the frequency of the ACE DD genotype (OR = 0.62, 95% CI = 0.44, 0.87; P < 0.01) and the D allele (OR = 0.66, 95% CI = 0.54, 0.82; P < 0.01) was significantly lower in psoriasis patients compared to the control group. No statistically significant differences were observed when stratified by blood pressure and blood glucose abnormalities (P > 0.05).

Conclusion: The ACE II genotype and I allele are risk factors for psoriasis vulgaris in the Northern Chinese Han population.

目的:血管紧张素转换酶(ACE)基因插入/缺失(I/D)多态性与银屑病之间的关系尚不清楚。本研究旨在分析中国汉族人群中血管紧张素转换酶基因 I/D 多态性与寻常型银屑病发病风险之间的关系,并探讨血管紧张素转换酶基因 I/D 多态性与银屑病合并高血压和糖尿病之间的相关性:方法:从中国汉族人群中选取了 358 名寻常型银屑病患者和 347 名年龄和性别匹配的健康志愿者。收集了患者的临床数据,包括血压和空腹血糖。聚合酶链式反应(PCR)分析了 ACE 基因 I/D 多态性。用皮尔逊χ²检验分析了ACE基因I/D多态性与寻常型银屑病、合并高血压和糖尿病之间的关系:与对照组相比,银屑病患者中 ACE II 基因型(OR = 1.84,95% CI = 1.30,2.61;P < 0.01)和 I 等位基因(OR = 1.51,95% CI = 1.22,1.86;P < 0.01)的频率明显较高。相反,与对照组相比,银屑病患者中 ACE DD 基因型(OR = 0.62,95% CI = 0.44,0.87;P <0.01)和 D 等位基因(OR = 0.66,95% CI = 0.54,0.82;P <0.01)的频率明显较低。按血压和血糖异常分层后,未观察到有统计学意义的差异(P > 0.05):结论:在中国北方汉族人群中,ACE II 基因型和 I 等位基因是寻常型银屑病的危险因素。
{"title":"The Relationship Between Angiotensin-Converting Enzyme Gene I/D Polymorphism and Psoriasis, Including Psoriasis with Comorbid Hypertension and Diabetes.","authors":"Jiayun Liu, Rui Sun, Guomin Gao, Mogen Zhang, Huiping Fan, Xiaonan Ma, Yanhong Yu, Yanmei Yuan, Lulu Zhang, Changying Niu","doi":"10.2147/CCID.S482663","DOIUrl":"10.2147/CCID.S482663","url":null,"abstract":"<p><strong>Objective: </strong>The relationship between angiotensin-converting enzyme (ACE) insertion/deletion (I/D) gene polymorphism and psoriasis remains unclear. This study aims to analyze the association between ACE gene I/D polymorphism and the risk of psoriasis vulgaris in the Chinese Han population and to examine the correlation between ACE gene I/D polymorphism and psoriasis with comorbid hypertension and diabetes.</p><p><strong>Methods: </strong>A total of 358 patients with psoriasis vulgaris and 347 age- and sex-matched healthy volunteers from the Chinese Han population were selected. Clinical data, including blood pressure and fasting blood glucose, were collected from the patients. The ACE gene I/D polymorphism was analyzed using polymerase chain reaction (PCR). The association between ACE gene I/D polymorphism and psoriasis vulgaris, as well as comorbid hypertension and diabetes, was analyzed using the Pearson <i>χ²</i>-test.</p><p><strong>Results: </strong>The frequency of the ACE II genotype (OR = 1.84, 95% CI = 1.30, 2.61; <i>P</i> < 0.01) and the I allele (OR = 1.51, 95% CI = 1.22, 1.86; <i>P</i> < 0.01) was significantly higher in psoriasis patients compared to the control group. Conversely, the frequency of the ACE DD genotype (OR = 0.62, 95% CI = 0.44, 0.87; <i>P</i> < 0.01) and the D allele (OR = 0.66, 95% CI = 0.54, 0.82; <i>P</i> < 0.01) was significantly lower in psoriasis patients compared to the control group. No statistically significant differences were observed when stratified by blood pressure and blood glucose abnormalities (<i>P</i> > 0.05).</p><p><strong>Conclusion: </strong>The ACE II genotype and I allele are risk factors for psoriasis vulgaris in the Northern Chinese Han population.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"17 ","pages":"2537-2543"},"PeriodicalIF":1.9,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11566204/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142646949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World Evidence. 评估双效面部注射剂的特性:从临床前数据到现实世界的证据。
IF 1.9 4区 医学 Q3 DERMATOLOGY Pub Date : 2024-11-10 eCollection Date: 2024-01-01 DOI: 10.2147/CCID.S474587
Patricia Ormiga, Claudia A Hernández, Rogério de Lima Romeiro, Aude Bernardin, Fabio Sambatti Crema, Lauren Nakab, Lital Shklanovsky, Graeme Kerson
{"title":"Evaluating the Properties of a Dual-Effect Facial Injectable: From Preclinical Data to Real-World Evidence.","authors":"Patricia Ormiga, Claudia A Hernández, Rogério de Lima Romeiro, Aude Bernardin, Fabio Sambatti Crema, Lauren Nakab, Lital Shklanovsky, Graeme Kerson","doi":"10.2147/CCID.S474587","DOIUrl":"10.2147/CCID.S474587","url":null,"abstract":"","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"17 ","pages":"2533-2536"},"PeriodicalIF":1.9,"publicationDate":"2024-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Non-HDL to HDL Cholesterol Ratio (NHHR) and Psoriasis in Adults: A Cross-Sectional Study Using 2009-2014 Data. 成人非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇之比 (NHHR) 与银屑病之间的关系:使用 2009-2014 年数据的横断面研究。
IF 1.9 4区 医学 Q3 DERMATOLOGY Pub Date : 2024-11-09 eCollection Date: 2024-01-01 DOI: 10.2147/CCID.S492053
Yizi Jiang, Min Jia

Background: Because of its possible significance in metabolic diseases, the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) has garnered attention as a novel and trustworthy lipid biomarker. Psoriasis may be linked to metabolic problems and obesity, according earlier research. Uncertainty surrounds the relationship between NHHR and the onset of psoriasis, though. The primary aim of this investigation was to examine the relationship between NHHR and psoriasis.

Patients and methods: This cross-sectional analysis used data from the National Health and Nutrition Examination Survey (NHANES) conducted between 2009 and 2014. The association between psoriasis and NHHR was examined using multivariate logistic regression, and smoothed curve fitting was done to explore the non-linear relationship. Furthermore, Subgroup and sensitivity studies were performed in order to confirm the robustness of the findings.

Results: Psoriasis and NHHR were shown to be positively correlated in 15,951 adult individuals who were at least 20 years old. Psoriasis risk rose by 7% for each unit increase in NHHR [1.07 (1.01, 1.14)]. Individuals in the highest NHHR tertile were 39% more likely compared to those in the bottom tertile to have psoriasis [1.39 (1.09, 1.78)]. Across subgroups, this favorable connection remained consistent.

Conclusion: Elevated NHHR levels are positively correlated with an upsurge chance of psoriasis in the adult population in the United States. The significance of NHHR as an indication for early psoriasis risk assessment is shown by this study.

背景:非高密度脂蛋白胆固醇与高密度脂蛋白胆固醇的比值(NHHR)在代谢性疾病中可能具有重要意义,因此作为一种新颖、可信的血脂生物标记物而备受关注。早期研究表明,牛皮癣可能与代谢问题和肥胖有关。不过,NHHR 与银屑病发病之间的关系尚不确定。这项调查的主要目的是研究 NHHR 与银屑病之间的关系:这项横断面分析使用了 2009 年至 2014 年间进行的美国国家健康与营养调查(NHANES)的数据。使用多变量逻辑回归研究了银屑病与 NHHR 之间的关系,并进行了平滑曲线拟合以探索非线性关系。此外,还进行了分组和敏感性研究,以确认研究结果的稳健性:在 15951 名至少 20 岁的成年人中,牛皮癣与 NHHR 呈正相关。NHHR 每增加一个单位,银屑病风险就会增加 7% [1.07 (1.01, 1.14)]。国家健康和生殖健康状况指数最高三分位数的人患银屑病的几率比最低三分位数的人高 39% [1.39 (1.09, 1.78)]。结论:NHHR 水平的升高与银屑病的发病率呈正相关:结论:NHHR 水平升高与美国成人银屑病发病率上升呈正相关。本研究表明,NHHR 是早期银屑病风险评估的重要指标。
{"title":"Association Between Non-HDL to HDL Cholesterol Ratio (NHHR) and Psoriasis in Adults: A Cross-Sectional Study Using 2009-2014 Data.","authors":"Yizi Jiang, Min Jia","doi":"10.2147/CCID.S492053","DOIUrl":"10.2147/CCID.S492053","url":null,"abstract":"<p><strong>Background: </strong>Because of its possible significance in metabolic diseases, the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) has garnered attention as a novel and trustworthy lipid biomarker. Psoriasis may be linked to metabolic problems and obesity, according earlier research. Uncertainty surrounds the relationship between NHHR and the onset of psoriasis, though. The primary aim of this investigation was to examine the relationship between NHHR and psoriasis.</p><p><strong>Patients and methods: </strong>This cross-sectional analysis used data from the National Health and Nutrition Examination Survey (NHANES) conducted between 2009 and 2014. The association between psoriasis and NHHR was examined using multivariate logistic regression, and smoothed curve fitting was done to explore the non-linear relationship. Furthermore, Subgroup and sensitivity studies were performed in order to confirm the robustness of the findings.</p><p><strong>Results: </strong>Psoriasis and NHHR were shown to be positively correlated in 15,951 adult individuals who were at least 20 years old. Psoriasis risk rose by 7% for each unit increase in NHHR [1.07 (1.01, 1.14)]. Individuals in the highest NHHR tertile were 39% more likely compared to those in the bottom tertile to have psoriasis [1.39 (1.09, 1.78)]. Across subgroups, this favorable connection remained consistent.</p><p><strong>Conclusion: </strong>Elevated NHHR levels are positively correlated with an upsurge chance of psoriasis in the adult population in the United States. The significance of NHHR as an indication for early psoriasis risk assessment is shown by this study.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"17 ","pages":"2523-2531"},"PeriodicalIF":1.9,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unexpected Repigmentation of Vitiligo Universalis Following Hemodialysis Initiation: A Rare Case Report and Literature Overview. 开始血液透析后泛发型白癜风的意外再色素沉着:罕见病例报告与文献综述。
IF 1.9 4区 医学 Q3 DERMATOLOGY Pub Date : 2024-11-08 eCollection Date: 2024-01-01 DOI: 10.2147/CCID.S482396
Abdulaziz A Alnoshan, Fahad Hamoud Alrashdi, Rawan Abdulaziz AlDahash, Khalid Nabil Nagshabandi, Salman Alotaibi

Vitiligo is a chronic skin depigmentation disorder affecting 0.2-1.8% of the global population, with a significant prevalence in Saudi Arabia. Although not life-threatening, it severely impacts the quality of life and psychological well-being of patients. We report a rare instance of hemodialysis-induced skin repigmentation involving a 25-year-old woman with vitiligo universalis.

白癜风是一种慢性皮肤色素脱失症,占全球人口的 0.2%-1.8%,在沙特阿拉伯的发病率很高。虽然不会危及生命,但它严重影响患者的生活质量和心理健康。我们报告了一例罕见的血液透析诱发皮肤再色素沉着的病例,患者是一名患有泛发型白癜风的 25 岁女性。
{"title":"Unexpected Repigmentation of Vitiligo Universalis Following Hemodialysis Initiation: A Rare Case Report and Literature Overview.","authors":"Abdulaziz A Alnoshan, Fahad Hamoud Alrashdi, Rawan Abdulaziz AlDahash, Khalid Nabil Nagshabandi, Salman Alotaibi","doi":"10.2147/CCID.S482396","DOIUrl":"https://doi.org/10.2147/CCID.S482396","url":null,"abstract":"<p><p>Vitiligo is a chronic skin depigmentation disorder affecting 0.2-1.8% of the global population, with a significant prevalence in Saudi Arabia. Although not life-threatening, it severely impacts the quality of life and psychological well-being of patients. We report a rare instance of hemodialysis-induced skin repigmentation involving a 25-year-old woman with vitiligo universalis.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"17 ","pages":"2519-2522"},"PeriodicalIF":1.9,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FOXN3 Regulates Autophagic Activity to Suppress Drug Resistance in Melanoma Cells. FOXN3 调控自噬活性以抑制黑色素瘤细胞的抗药性
IF 1.9 4区 医学 Q3 DERMATOLOGY Pub Date : 2024-11-07 eCollection Date: 2024-01-01 DOI: 10.2147/CCID.S462854
Yaqi Wang, Hui Su, Xiaopeng Wang, Chen Tu, Tong Xiao, Bincheng Ren, Shuang Wang

Background: The forkhead box (FOX) family member FOXN3 has been reported to inhibit transcriptional activity associated with regulating tumor development. However, the role of FOXN3 in the pathogenesis of melanoma is not well understood.

Objective: To investigate the biological functions of FOXN3 in drug resistance of melanoma.

Materials and methods: The expression of FOXN3 in melanoma was investigated using Gene Expression profiling interactive analysis (GEPIA) and Linkedomics databases. Melanoma cell proliferation, invasion, and migration were assessed using the colony formation assay, the scratch wound healing test, the Transwell invasion assay, and the nude mice xenograft to determine the effects of FOXN3 over-expression and depletion. The functional role of the transcriptional regulator in melanoma cells was tested through chromatin immunoprecipitation, immunofluorescence.

Results: FOXN3 was downregulated in melanoma. Over-expression of FOXN3 inhibited the proliferation and motility of melanoma cells, whereas FOXN3 knockdown significantly enhanced the proliferation and motility of melanoma cells. Overexpression of FOXN3 reduced autophagic activity in melanoma cells. Enhanced autophagic activity in drug-resistant melanoma cell lines is related to drug-sensitive cells, and significant differences in FOXN3 localization were observed when comparing melanoma cells that were sensitive and resistant to Vemurafenib. Additionally, FOXN3 has been identified as binding to the promoter region of the cancer antigen Fibrous Sheath Interacting Protein 1 (FSIP1), thereby regulating the expression of this gene.

Conclusion: FOXN3 functions as an important regulator of the development and progression of Vemurafenib-resistant melanoma cells, partly owing to its binding to the FISP1. As such, FOXN3 may represent a relevant target for therapeutic interventions in patients suffering from drug-resistant melanoma.

背景:据报道,叉头盒子(FOX)家族成员FOXN3可抑制与调控肿瘤发生有关的转录活性。然而,FOXN3在黑色素瘤发病机制中的作用尚不十分清楚:材料与方法:使用基因表达谱交互分析(GEPIA)和Linkedomics数据库研究FOXN3在黑色素瘤中的表达。采用集落形成试验、划痕伤口愈合试验、Transwell侵袭试验和裸鼠异种移植等方法评估了黑色素瘤细胞的增殖、侵袭和迁移,以确定FOXN3过度表达和缺失的影响。通过染色质免疫沉淀和免疫荧光检测了该转录调节因子在黑色素瘤细胞中的功能作用:结果:FOXN3在黑色素瘤中下调。结果:FOXN3 在黑色素瘤中被下调,过表达 FOXN3 会抑制黑色素瘤细胞的增殖和运动,而敲除 FOXN3 则会显著增强黑色素瘤细胞的增殖和运动。过表达 FOXN3 会降低黑色素瘤细胞的自噬活性。耐药黑色素瘤细胞系自噬活性的增强与对药物敏感的细胞有关,在比较对维莫非尼敏感和耐药的黑色素瘤细胞时,观察到了FOXN3定位的显著差异。此外,还发现FOXN3与癌症抗原纤维鞘相互作用蛋白1(FSIP1)的启动子区域结合,从而调节该基因的表达:结论:FOXN3对维莫非尼耐药的黑色素瘤细胞的发育和进展起着重要的调节作用,部分原因是它与FISP1结合。因此,FOXN3可能是耐药黑色素瘤患者治疗干预的相关靶点。
{"title":"FOXN3 Regulates Autophagic Activity to Suppress Drug Resistance in Melanoma Cells.","authors":"Yaqi Wang, Hui Su, Xiaopeng Wang, Chen Tu, Tong Xiao, Bincheng Ren, Shuang Wang","doi":"10.2147/CCID.S462854","DOIUrl":"https://doi.org/10.2147/CCID.S462854","url":null,"abstract":"<p><strong>Background: </strong>The forkhead box (FOX) family member FOXN3 has been reported to inhibit transcriptional activity associated with regulating tumor development. However, the role of FOXN3 in the pathogenesis of melanoma is not well understood.</p><p><strong>Objective: </strong>To investigate the biological functions of FOXN3 in drug resistance of melanoma.</p><p><strong>Materials and methods: </strong>The expression of FOXN3 in melanoma was investigated using Gene Expression profiling interactive analysis (GEPIA) and Linkedomics databases. Melanoma cell proliferation, invasion, and migration were assessed using the colony formation assay, the scratch wound healing test, the Transwell invasion assay, and the nude mice xenograft to determine the effects of FOXN3 over-expression and depletion. The functional role of the transcriptional regulator in melanoma cells was tested through chromatin immunoprecipitation, immunofluorescence.</p><p><strong>Results: </strong>FOXN3 was downregulated in melanoma. Over-expression of FOXN3 inhibited the proliferation and motility of melanoma cells, whereas FOXN3 knockdown significantly enhanced the proliferation and motility of melanoma cells. Overexpression of FOXN3 reduced autophagic activity in melanoma cells. Enhanced autophagic activity in drug-resistant melanoma cell lines is related to drug-sensitive cells, and significant differences in FOXN3 localization were observed when comparing melanoma cells that were sensitive and resistant to Vemurafenib. Additionally, FOXN3 has been identified as binding to the promoter region of the cancer antigen Fibrous Sheath Interacting Protein 1 (FSIP1), thereby regulating the expression of this gene.</p><p><strong>Conclusion: </strong>FOXN3 functions as an important regulator of the development and progression of Vemurafenib-resistant melanoma cells, partly owing to its binding to the <i>FISP1</i>. As such, FOXN3 may represent a relevant target for therapeutic interventions in patients suffering from drug-resistant melanoma.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"17 ","pages":"2505-2518"},"PeriodicalIF":1.9,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11552389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Overview of Commonly Used Natural Alternatives for the Treatment of Androgenetic Alopecia, with Special Emphasis on Rosemary Oil. 治疗雄激素性脱发的常用天然替代品概述,特别强调迷迭香精油。
IF 1.9 4区 医学 Q3 DERMATOLOGY Pub Date : 2024-11-05 eCollection Date: 2024-01-01 DOI: 10.2147/CCID.S470989
Nouf F Bin Rubaian, Haya Fahad Abdulaziz Alzamami, Baraa Abdulrazack Amir

Androgenetic alopecia is a chronic dermatological condition in which genetically predisposed individuals undergo progressive hair loss secondary to the effects of circulating androgens. It has been well documented that dihydrotestosterone binds to the androgenic receptors prevalent in the scalp, thus inducing miniaturization of the hair follicle. To date, the only FDA approved medications for the treatment of androgenetic alopecia are finasteride and minoxidil. A plethora of studies have been conducted testing the efficacy of various herbal compounds, but additional research is needed to further establish the concrete efficacy of such natural remedies in treating androgenetic alopecia. Of late, rosemary oil has gained mass popularity as a promising natural alternative. This review article will not only provide a detailed background on this ancient herbal component but will additionally overview all other major herbal alternatives including peppermint oil, tea tree oil, green tea, pumpkin seed oil, saw palmetto, and lavender oil and will summarize the latest clinical studies, which have tested their efficacy for the management of androgenetic alopecia.

雄激素性脱发是一种慢性皮肤病,具有遗传易感性的人在循环雄激素的作用下会出现进行性脱发。有充分证据表明,双氢睾酮会与头皮中普遍存在的雄激素受体结合,从而导致毛囊小型化。迄今为止,美国食品及药物管理局批准用于治疗雄激素性脱发的药物只有非那雄胺和米诺地尔。已有大量研究对各种草药化合物的疗效进行了测试,但要进一步确定这些天然疗法治疗雄激素性脱发的具体疗效,还需要进行更多的研究。最近,迷迭香精油作为一种很有前景的天然替代品受到了大众的欢迎。这篇综述文章不仅将详细介绍这种古老草药成分的背景,还将概述所有其他主要草药替代品,包括薄荷油、茶树油、绿茶、南瓜籽油、锯棕榈和薰衣草油,并将总结最新的临床研究,这些研究已经测试了它们在治疗雄激素性脱发方面的功效。
{"title":"An Overview of Commonly Used Natural Alternatives for the Treatment of Androgenetic Alopecia, with Special Emphasis on Rosemary Oil.","authors":"Nouf F Bin Rubaian, Haya Fahad Abdulaziz Alzamami, Baraa Abdulrazack Amir","doi":"10.2147/CCID.S470989","DOIUrl":"https://doi.org/10.2147/CCID.S470989","url":null,"abstract":"<p><p>Androgenetic alopecia is a chronic dermatological condition in which genetically predisposed individuals undergo progressive hair loss secondary to the effects of circulating androgens. It has been well documented that dihydrotestosterone binds to the androgenic receptors prevalent in the scalp, thus inducing miniaturization of the hair follicle. To date, the only FDA approved medications for the treatment of androgenetic alopecia are finasteride and minoxidil. A plethora of studies have been conducted testing the efficacy of various herbal compounds, but additional research is needed to further establish the concrete efficacy of such natural remedies in treating androgenetic alopecia. Of late, rosemary oil has gained mass popularity as a promising natural alternative. This review article will not only provide a detailed background on this ancient herbal component but will additionally overview all other major herbal alternatives including peppermint oil, tea tree oil, green tea, pumpkin seed oil, saw palmetto, and lavender oil and will summarize the latest clinical studies, which have tested their efficacy for the management of androgenetic alopecia.</p>","PeriodicalId":10447,"journal":{"name":"Clinical, Cosmetic and Investigational Dermatology","volume":"17 ","pages":"2495-2503"},"PeriodicalIF":1.9,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11549889/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142616096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical, Cosmetic and Investigational Dermatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1